Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP)

Low-avidity anti-HPA-1a alloantibodies are capable of antigen-positive platelet destruction in the NOD/SCID mouse model of alloimmune thrombocytopenia

(2011) Tamam Bakchoul et al.   TRANSFUSION

Complement activation in vitro by antiplatelet antibodies in chronic immune thrombocytopenic purpura

(2010) T. Tsubakio et al.   BRITISH JOURNAL OF HAEMATOLOGY

Warm Autoimmune Hemolytic Anemia: Recent Progress in Understanding the Immunobiology and the Treatment

(2010) Melca M.O. Barros et al.   TRANSFUSION MEDICINE REVIEWS

International consensus report on the investigation and management of primary immune thrombocytopenia

(2009) D. Provan et al.   BLOOD

The ITP syndrome: pathogenic and clinical diversity

(2009) D. B. Cines et al.   BLOOD

Complement activation on platelets correlates with a decrease in circulating immature platelets in patients with immune thrombocytopenic purpura

(2009) Ellinor I. B. Peerschke et al.   BRITISH JOURNAL OF HAEMATOLOGY

Prospective evaluation of PF4/heparin immunoassays for the diagnosis of heparin-induced thrombocytopenia

(2009) T. BAKCHOUL et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Expression of complement components and inhibitors on platelet microparticles

(2008) Wei Yin et al.   PLATELETS